Table 1 Clinical trials of CC-122 in cancer
Phase | Conditions | Interventions | NCT ID |
|---|---|---|---|
1 | MM, NHL, solid tumors | CC-122 | NCT01421524 |
1 | DLBCL, iNHL | CC-122, obinutuzumab | NCT02417285 |
1 | DLBCL, FL | CC-122, rituximab, CC-223, CC-292 | NCT02031419 |
1, 2 | DLBCL | CC-122, R-CHOP | NCT03283202 |
1 | NHL | CC-122 | NCT02509039 |
1, 2 | CLL, SLL | CC-122, ibrutinib, obinutuzumab | NCT02406742 |
1, 2 | HCC | CC-122, nivolumab | NCT02859324 |
2 | Melanoma | CC-122, nivolumab | NCT03834623 |